Advisor Group Holdings »

Theriva Biologics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $147 444 0.33
2025-06-30 $147 444 0.33
2025-03-31 $884 884 1.00
2024-12-31 $2.3k 1.3k 1.75
2024-09-30 $1.8k 1.3k 1.38

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Spdr Series Trust Portfolio S&p500 (SPLG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Technology (XLK)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Advisor Group Holdings

Top funds holding Theriva Biologics

Ikarian Capital
Two Sigma Investments
Virtu Financial
Jane Street
Boothbay Fund Management
XTX Topco
Geode Capital Management
Two Sigma Advisers
UBS Group
Vanguard Group
Hrt Financial
BlackRock
Advisor Group Holdings
Clear Street
SBI Securities

View all funds holding Theriva Biologics